US EditionPublished • loading... • Updated
Zepbound With Taltz Reduces Psoriasis and Psoriatic Arthritis Symptoms, Clinical Trials Show
Summary by EverydayHealth.com
1 Articles
1 Articles
Zepbound With Taltz Reduces Psoriasis and Psoriatic Arthritis Symptoms, Clinical Trials Show
When obesity is treated alongside psoriasis or psoriatic arthritis, skin and joint symptoms may improve more than when inflammation is targeted alone, according to new clinical trial results from the pharmaceutical company Eli Lilly. In two late-stage (phase 3b) studies, adults with moderate to severe plaque psoriasis or active psoriatic arthritis (PsA) who received the biologic Taltz (ixekizumab) together with the GLP-1 obesity medication Zepbo…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
